Adult SmokersESCMMPNCT00529256
Evaluation of Organisational Changes to Promote Smoking Cessation
A study testing Feeback group in people with Adult Smokers, run by Great Lakes Research Into Practice Network at 1 site in United States.
Trial summary
The Department of Family Practice at Michigan State University partnered with BCBSM with a grant from the Robert Wood Johnson Foundation to recruit primary care practices for a 3 year study designed to assess smoking cessation referral rates by primary care physicians in Michigan. Read more about this study
- Who is it for?
- Ages 18 to 85 yearsHealthy volunteers can take part
- Conditions the study is for
- Adult Smokers
- What is being tested?
- Feeback group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 87 participants
- Where
- 1 siteUnited States
- Study dates
- Dec 2001to Apr 2005
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Primary care practice and thier Adult smokers
Who cannot join
- Non somkers
Trial locations and contacts
1 site in 1 country.
About this study
The Department of Family Practice at Michigan State University partnered with BCBSM with a grant from the Robert Wood Johnson Foundation to recruit primary care practices for a 3 year study designed to assess smoking cessation referral rates by primary care physicians in Michigan.
Read the detailed description
There are two main research questions to our study: 1) Whether provider referral rates to smoking cessation services and quitline counseling are enhanced by comparative feedback profiles to individual providers and provider groups (Study 1) and 2) Whether health plan members who receive pharmacotherapy for smoking cessation have higher participation rates in smoking cessation services if they receive proactive, invitational phone calls (Study 2).
- Conditions
- Adult Smokers
- Being tested
- Feeback group
- Keywords
- Adult smokers
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Feeback groupBehavioural
The intervention practices received a quarterly comparative feedback performance report based on the Achievable Benchmarks of Care (ABC) research conducted by Kieffe (YEAR).
| Study group | Role | What they receive |
|---|---|---|
| 2 | No intervention | No intervention Receives: Behavioral: Feeback group |
What is being measured
The primary outcome is the main question the study is designed to answer.
evaluate and provide a model of smoking cessation interventions
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2007 (estimated)
- Study startDec 2001
- Study completionApr 2005
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Adult SmokersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 87 participants (actual)
Sponsor and investigators
- Lead sponsor
- Great Lakes Research Into Practice Network
- Sponsor type
- Research network
- Collaborators
- Robert Wood Johnson Foundation
- Investigators
- William Wadland, MD, MS, Principal investigator, Michigan State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00529256
- Sponsor's protocol ID
- 61-6498
- Acronym
- ESCMMP
- Status last verified
- Apr 2005
- First submitted
- 11 Sep 2007
- Last updated
- 14 Sep 2007
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Holtrop JS, Malouin R, Weismantel D, Wadland WC. Clinician perceptions of factors influencing referrals to a smoking cessation program. BMC Fam Pract. 2008 Mar 28;9:18. doi: 10.1186/1471-2296-9-18.
PubMed 18373854
Study at a glance
From the registry record, last updated by the sponsor on 14 Sep 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Organisational Changes to Promote Smoking Cessation
- ClinicalTrials.gov ID
- NCT00529256
- Acronym / sponsor ID
- ESCMMP / 61-6498
- Conditions
- Adult Smokers
- Keywords
- Adult smokers
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 87 participants (actual)
- Lead sponsor
- Great Lakes Research Into Practice NetworkResearch network
- Collaborators
- Robert Wood Johnson Foundation
- Study start
- Dec 2001
- Study completion
- Apr 2005 (actual)
- First posted
- 14 Sep 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Department of Family Practice at Michigan State University partnered with BCBSM with a grant from the Robert Wood Johnson Foundation to recruit primary care practices for a 3 year study designed to assess smoking cessation referral rates by primary care physicians in Michigan.
Detailed description
There are two main research questions to our study: 1) Whether provider referral rates to smoking cessation services and quitline counseling are enhanced by comparative feedback profiles to individual providers and provider groups (Study 1) and 2) Whether health plan members who receive pharmacotherapy for smoking cessation have higher participation rates in smoking cessation services if they receive proactive, invitational phone calls (Study 2).
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 2 | No intervention | Behavioral: Feeback groupNo intervention |
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Primary care practice and thier Adult smokers
Key exclusion criteria (1 listed)
- Non somkers
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Feeback groupThe intervention practices received a quarterly comparative feedback performance report based on the Achievable Benchmarks of Care (ABC) research conducted by Kieffe (YEAR). | Behavioural | 2 |
Primary outcome
evaluate and provide a model of smoking cessation interventions
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Sep 2007.
- Derived from this study: PubMed 18373854Holtrop JS, Malouin R, Weismantel D, Wadland WC. Clinician perceptions of factors influencing referrals to a smoking cessation program. BMC Fam Pract. 2008 Mar 28;9:18. doi: 10.1186/1471-2296-9-18.
Related trials for Adult Smokers
Active, not recruiting
Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants
Smoking
Not yet recruitingPhase 2
A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Disease, Chronic Obstructive
Not yet recruiting
Studying Different Ways of Using Oral Nicotine Pouches to Understand the Effect on Nicotine Delivery, Appeal, and Side Effects Among Adult Cigarette Smokers
Cigarette Smoking-Related Carcinoma
Recruiting
The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers
Smoking Reduction
RecruitingPhase 2
Semaglutide for Post-Smoking Cessation Weight Management
Obesity, Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
William Wadland, MD, MS principal investigator
Michigan State University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Feeback group in people with Adult Smokers, run by Great Lakes Research Into Practice Network at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Sep 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
evaluate and provide a model of smoking cessation interventions. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00529256, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2007.